Metoject solution + syringe 0.35ml 17.5mg 50mg/ml Cancert Методжект

Metoject Indicantions

Prevents the proliferation of tumor cells

Contradictions

Hypersensitivity to methotrexate or to any of the components;
liver dysfunction (liver disease caused by alcohol, or other chronic liver disease);
alcohol abuse;
blood diseases in history, such as bone marrow hypoplasia, leukocytopenia, thrombocytopenia or severe anemia;
severe acute or chronic infections such as tuberculosis and HIV, or other immunodeficiency syndromes;
ulcers in the oral cavity and ulcers in the stomach or intestine in active form;
Renal impairment (creatinine clearance less than 60 ml / min);
concomitant vaccination with live vaccines;
pregnancy and breastfeeding.

Dosage & Administration

The appointment of Methodoget should be by doctors who have experience and know all the features of this drug and its mechanism of action.

Methodoget should be administered once a week.

The patient should be clearly informed that the drug should be administered once a week. It is advisable to set a fixed day of the week as an injection day.